Do cancer cells undergo phenotypic switching? the case for imperfect cancer stem cell markers

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Zapperi, Stefano ^a,b   La Porta, Caterina A M ^c  

^a CNR   (Italy)

^b ISI FOUNDATION   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ALGORITHM; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CANCER STEM CELL; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHENOTYPE; PROBABILITY; TUMOR MICROENVIRONMENT;

ALGORITHMS; ANIMALS; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MARKOV CHAINS; MODELS, GENETIC; NEOPLASMS; NEOPLASTIC STEM CELLS; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84862014006     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00441     Document Type: Article

References (37)

1. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38, 2651-60 (1978). (Pubitemid 9001502)
2. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. NatMed 3, 730-737 (1997). (Pubitemid 27298715)
3. La Porta, C. Cancer stem cells: lessons from melanoma. Stem Cell Rev 5, 61-5 (2009).
4. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-44 (2011).
5. Brock, A., Chang, H. & Huang, S. Non-genetic heterogeneity-a mutationindependent driving force for the somatic evolution of tumours. Nat Rev Genet 10, 336-42 (2009).
6. Turner, B. M. Epigenetic responses to environmental change and their evolutionary implications. Philos Trans R Soc Lond B Biol Sci 364, 3403-18 (2009).
7. Quintana, E. et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510-23 (2010).
8. Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-94 (2010).
9. Schatton, T. et al. Identification of cells initiating humanmelanomas. Nature 451, 345-349 (2008).
10. Held, M. A. et al. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 70, 388-97 (2010).
11. La Porta, C. A. M., Zapperi, S. & Sethna, J. P. Senescent cells in growing tumors: population dynamics and cancer stem cells. PLoS Comput Biol 8, e1002316 (2012).
12. Harris, T. E. The theory of branching processes (Dover, New York, 1989).
13. Kimmel, M. & Axelrod, D. E. Branching processes in biology (Springer, New York, 2002).
14. Vogel, H., Niewisch, H. & Matioli, G. The self renewal probability of hemopoietic stem cells. J Cell Physiol 72, 221-8 (1968).
15. Matioli, G., Niewisch, H. & Vogel, H. Stochastic stem cell renewal. Rev Eur Etud Clin Biol 15, 20-2 (1970).
16. Potten, C. S. & Morris, R. J. Epithelial stem cells in vivo. J Cell Sci Suppl 10, 45-62 (1988). (Pubitemid 19096574)
17. Clayton, E. et al. A single type of progenitor cell maintains normal epidermis. Nature 446, 185-9 (2007). (Pubitemid 46398664)
18. Antal, T. & Krapivsky, P. L. Exact solution of a two-type branching process: clone size distribution in cell division kinetics. Journal of Statistical Mechanics: Theory and Experiment 2010, P07028 (2010).
19. Itzkovitz, S., Blat, I. C., Jacks, T., Clevers, H. & van Oudenaarden, A. Optimality in the development of intestinal crypts. Cell 148, 608-19 (2012).
20. Michor, F. et al. Dynamics of chronic myeloid leukaemia. Nature 435, 1267-70 (2005). (Pubitemid 40943094)
21. Ashkenazi, R., Gentry, S. N. & Jackson, T. L. Pathways to tumorigenesis-modeling mutation acquisition in stem cells and their progeny. Neoplasia 10, 1170-1182 (2008).
22. Michor, F. Mathematical models of cancer stem cells. J Clin Oncol 26, 2854-61 (2008).
23. Tomasetti, C. & Levy, D. Role of symmetric and asymmetric division of stem cells in developing drug resistance. Proc Natl Acad Sci U S A 107, 16766-71 (2010).
24. Sato, T. et al. Paneth cells constitute the niche for lgr5 stem cells in intestinal crypts. Nature 469, 415-8 (2011).
25. Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing lgr5 stem cells. Cell 143, 134-44 (2010).
26. Lopez-Garcia, C., Klein, A. M., Simons, B. D. & Winton, D. J. Intestinal stem cell replacement follows a pattern of neutral drift. Science 330, 822-5 (2010).
27. Naumov, G. N. et al. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112 (Pt 12), 1835-42 (1999). (Pubitemid 29338809)
28. La Porta, C. A. M. Mechanism of drug sensitivity and resistance in melanoma. Curr Cancer Drug Targets 9, 391-397 (2009).
29. Idowu, M. O. et al. Cd441/cd24a?/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Human Pathology -(2011).
30. Monzani, E. et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 43, 935-946 (2007). (Pubitemid 46366698)
31. Klein, W. M. et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20, 102-7 (2007). (Pubitemid 44967955)
32. Hadnagy, A., Gaboury, L., Beaulieu, R. & Balicki, D. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 312, 3701-10 (2006). (Pubitemid 44633895)
33. Keshet, G. I. et al. MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun 368, 930-6 (2008).
34. Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593-8 (2008).
35. Boiko, A. D. et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466, 133-137 (2010).
36. Taghizadeh, R. et al. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PLoS One 5, e15183 (2010).
37. Hoek, K. S. & Goding, C. R. Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23, 746-59 (2010).